Cargando…
Fulminant myocarditis: COVID or not COVID? Reinfection or co-infection?
We describe a unique case of fulminant myocarditis in a patient with presumed SARS-CoV-2 reinfection. Patient had initial infection 4 months backand had COVID-19 antibody at the time of presentation. Endomyocardial biopsy showed lymphocytic myocarditis, that is usually seen in viral myocarditis. The...
Autores principales: | Yeleti, Ramya, Guglin, Maya, Saleem, Kashif, Adigopula, Sasikanth V, Sinha, Anjan, Upadhyay, Smrity, Everett, Jeffrey E, Ballut, Kareem, Uppuluri, Sarada, Rao, Roopa A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919708/ https://www.ncbi.nlm.nih.gov/pubmed/33615872 http://dx.doi.org/10.2217/fca-2020-0237 |
Ejemplares similares
-
Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020
por: Guglin, Maya, et al.
Publicado: (2021) -
CLINICAL VARIANTS OF MYOCARDIAL INVOLVEMENT IN COVID-19 POSITIVE PATIENTS
por: Guglin, Maya E., et al.
Publicado: (2021) -
CLINICAL CHARACTERISTICS, OUTCOMES AND IMMUNOSUPPRESSION STRATEGIES OF HEART TRANSPLANT RECIPIENTS INFECTED WITH COVID-19
por: Ilonze, Onyedika J., et al.
Publicado: (2021) -
Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review
por: Guglin, Maya E., et al.
Publicado: (2023) -
SARS-CoV-2 infection in heart transplant recipients: a systematic literature review of clinical outcomes and immunosuppression strategies
por: Ilonze, Onyedika J., et al.
Publicado: (2021)